FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2419258667> ?p ?o ?g. }

• W2419258667 endingPage "15" @default.
• W2419258667 startingPage "7" @default.
• W2419258667 abstract "Treatment of prostate cancer (PC) is a challenge for both urologists and radiation oncologists. Currently, two radical methods of treatment are recommended in localized prostate cancer (PC)--i.e. radical prostatectomy (RP) and radiotherapy (RT) with excellent long-term results. However, the outcome of RT, which is the treatment of choice in locally advanced stages of the disease, is unsatisfactory due to the high risk of regional or distant metastases and local failure. Lately, hormonal therapy (HT), which had mainly been indicated for treatment of patients with distant metastases, has been added to radiotherapy to improve the efficacy of treatment. The general rationales for combining RT and HT are four-fold: decreasing prostate gland volume, diminishing the number of cancer cells, improving tumor oxygenation, and eliminating distant and regional micrometastases. Over the last 20 years several randomized clinical trials evaluating the results of combined HT and RT treatment have been carried out. The RTOG 85-31, RTOG 86-10, EORTC 22863 and RTOG 92-02 trials were completed from the mid 80s to the mid 90s and long-term follow-up data on all important end-points are now available. These data have been evaluated by panels of experts and served as the basis for the latest American (NCCN 2005) and European (EAU 2005) recommendations on prostate cancer. However, despite the long-term results of these trials, there are still no clear-cut answers to the following crucial questions: What is the optimal timing of hormonal therapy? What types of patients can benefit most from combined strategies? What is the spectrum and potential reversibility of side effects of long-term combined treatment? How does it influence the patients quality of life and care costs? Other questions concern the possible role of androgen deprivation therapy combined with brachytherapy. The only randomized trial to evaluate this issue to date was stopped due to incomplete accrual. Therefore, answers must be sought in the large body of nonrandomized studies. There is a constant need for properly designed randomized clinical trials to precisely identify the subgroup of patients who will benefit most from combined RT and HT treatment. Results of ongoing clinical trials (RTOG 9901, RTOG 9408) are expected to yield some answers to the questions mentioned above. Currently, we can conclude that in the group of patients with high risk of relapse (T3 or GS > 7 or PSA >20 ng/ml), combined hormonal and radiation therapy improves prostate cancer treatment results and should be highly recommended." @default.
• W2419258667 created "2016-06-24" @default.
• W2419258667 creator A5062635494 @default.
• W2419258667 creator A5063181876 @default.
• W2419258667 creator A5069099987 @default.
• W2419258667 date "2007-01-01" @default.
• W2419258667 modified "2023-09-24" @default.
• W2419258667 title "Radiotherapy combined with hormonal therapy (RT-HT) in prostate cancer patients with low, intermediate, and high risk of biochemical recurrence: perspective and therapeutic gain analysis." @default.
• W2419258667 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17203887" @default.
• W2419258667 hasPublicationYear "2007" @default.
• W2419258667 type Work @default.
• W2419258667 sameAs 2419258667 @default.
• W2419258667 citedByCount "6" @default.
• W2419258667 countsByYear W24192586672013 @default.
• W2419258667 countsByYear W24192586672015 @default.
• W2419258667 countsByYear W24192586672016 @default.
• W2419258667 crossrefType "journal-article" @default.
• W2419258667 hasAuthorship W2419258667A5062635494 @default.
• W2419258667 hasAuthorship W2419258667A5063181876 @default.
• W2419258667 hasAuthorship W2419258667A5069099987 @default.
• W2419258667 hasConcept C121608353 @default.
• W2419258667 hasConcept C126322002 @default.
• W2419258667 hasConcept C126894567 @default.
• W2419258667 hasConcept C143998085 @default.
• W2419258667 hasConcept C168563851 @default.
• W2419258667 hasConcept C2776235491 @default.
• W2419258667 hasConcept C2778311097 @default.
• W2419258667 hasConcept C2779134260 @default.
• W2419258667 hasConcept C2779466945 @default.
• W2419258667 hasConcept C2780192828 @default.
• W2419258667 hasConcept C509974204 @default.
• W2419258667 hasConcept C535046627 @default.
• W2419258667 hasConcept C71924100 @default.
• W2419258667 hasConceptScore W2419258667C121608353 @default.
• W2419258667 hasConceptScore W2419258667C126322002 @default.
• W2419258667 hasConceptScore W2419258667C126894567 @default.
• W2419258667 hasConceptScore W2419258667C143998085 @default.
• W2419258667 hasConceptScore W2419258667C168563851 @default.
• W2419258667 hasConceptScore W2419258667C2776235491 @default.
• W2419258667 hasConceptScore W2419258667C2778311097 @default.
• W2419258667 hasConceptScore W2419258667C2779134260 @default.
• W2419258667 hasConceptScore W2419258667C2779466945 @default.
• W2419258667 hasConceptScore W2419258667C2780192828 @default.
• W2419258667 hasConceptScore W2419258667C509974204 @default.
• W2419258667 hasConceptScore W2419258667C535046627 @default.
• W2419258667 hasConceptScore W2419258667C71924100 @default.
• W2419258667 hasIssue "1" @default.
• W2419258667 hasLocation W24192586671 @default.
• W2419258667 hasLocation W24192586672 @default.
• W2419258667 hasOpenAccess W2419258667 @default.
• W2419258667 hasPrimaryLocation W24192586671 @default.
• W2419258667 hasRelatedWork W114188019 @default.
• W2419258667 hasRelatedWork W1978002751 @default.
• W2419258667 hasRelatedWork W1984192990 @default.
• W2419258667 hasRelatedWork W1997694117 @default.
• W2419258667 hasRelatedWork W2022083274 @default.
• W2419258667 hasRelatedWork W2050277940 @default.
• W2419258667 hasRelatedWork W206187987 @default.
• W2419258667 hasRelatedWork W2068880040 @default.
• W2419258667 hasRelatedWork W2117324767 @default.
• W2419258667 hasRelatedWork W2195376666 @default.
• W2419258667 hasRelatedWork W2273751031 @default.
• W2419258667 hasRelatedWork W2282168600 @default.
• W2419258667 hasRelatedWork W2397304173 @default.
• W2419258667 hasRelatedWork W2409773005 @default.
• W2419258667 hasRelatedWork W2417299564 @default.
• W2419258667 hasRelatedWork W2436409877 @default.
• W2419258667 hasRelatedWork W3025076148 @default.
• W2419258667 hasRelatedWork W3181451815 @default.
• W2419258667 hasRelatedWork W33458836 @default.
• W2419258667 hasRelatedWork W2422707242 @default.
• W2419258667 hasVolume "54" @default.
• W2419258667 isParatext "false" @default.
• W2419258667 isRetracted "false" @default.
• W2419258667 magId "2419258667" @default.
• W2419258667 workType "article" @default.